Hepatitis E: update and perspectives

Journal Title: One Health & Risk Management - Year 2021, Vol 2, Issue 2

Abstract

Introduction. There are approximately 20 million cases of HVE annually worldwide, leading to approximately 3.3 million symptomatic cases of acute hepatitis E. The WHO estimates that HEV caused approximately 44,000 deaths in 2015 accounting for 3.3% of the mortality rate due to viral hepatitis. Material and methods. The study of 75 bibliographic sources was carried out. The scientific platforms EMBASE, PubMed, HINARI, data from the national libraries as well as international relevant reference data were thoroughly examined. Results. The present relevant study has highlighted important aspects of hepatitis E virus infection. Along with the improved living conditions and water quality standards, the latter being a disease-causing factor in the transmission of HEV, both the developed and developing countries are facing HEV, particularly in high-risk population groups, including people who are employed in the pork-processing industry and beneficiaries of blood transfusions. Conclusions. The countries' capacity to detect and control this infection is limited since it has not been included within the surveillance policies and programs yet. Risk factors associated with the epidemic process should be elucidated to provide and develop appropriate evidence-based measures to optimize the surveillance and control system in order to reduce the risk of contracting HEV and maintain favorable conditions for epidemiological safety.

Authors and Affiliations

Veaceslav GUȚU

Keywords

Related Articles

Current issues related to access and use of information on ex situ conservation of plant genetic resources in the Republic of Moldova

Introduction. The rapid development of information technologies has provided challenges and opportunities for effective documentation of plant genetic resources (PGR). Access to information on PGR is essential for their...

Atypical presentation of a high-grade astrocytoma in a pediatric rheumatology Practice

Introduction. Hip pain is common in childhood. The main dilemma is to differentiate between benign conditions and those causing significant morbidity and mortality. Material and methods. A clinical case report of a to...

The efficacy of direct-acting antiviral therapy in patients with chronic hepatitis C

Introduction. Viral hepatitis C (HCV) is a significant global health problem. The risk of developing chronic HCV is up to 80% of patients, of whom 10-20% can develop liver cirrhosis or hepatocellular carcinoma which can...

Geographical differentiation of mortality in the Republic of Moldova

Introduction. Life expectancy in Moldova after independence either fluctuated in the 1990s or stagnated in the early millennium, followed by moderate improvements since 2010. The objective of the stu...

The use of biomass of Streptomycetes as a stimulator of some body indices of chickens

Introduction. Currently, various biologically active substances, preferably of biological and not synthetic origin, with having a growth stimulating effect, are frequently used as food additives in the poultry industry....

Download PDF file
  • EP ID EP693659
  • DOI 10.38045/ohrm.2021.2.01
  • Views 128
  • Downloads 0

How To Cite

Veaceslav GUȚU (2021). Hepatitis E: update and perspectives. One Health & Risk Management, 2(2), -. https://europub.co.uk/articles/-A-693659